• Support the development and refinement of the global commercial strategy for empasiprubart across current and future pipeline indications, in alignment with argenx Vision 2030 • Lead commercial insights generation, including opportunity assessments, competitive analysis, patient journey mapping, and indication prioritization • Contribute to Target Product Profile (TPP) development and payer testing efforts, aligned with activities referenced in empasiprubart workstreams (e.g., TPP payer testing) to inform pricing and global access strategy • Serve as a key commercial partner within the empasiprubart Indication Development Teams (IDTs), ensuring integration of commercial perspectives into clinical, regulatory, HEOR, and medical plans • Partner with the Global Launch Leads to create a seamless transition from strategic planning into launch execution • Collaborate with Market Access, HEOR, and Pricing to ensure evidence‑generation plans meet payer expectations globally • Shape pre‑launch activities including disease education, early access strategy planning, stakeholder mapping, and channel strategy • Support brand strategy foundations including positioning, segmentation, messaging frameworks, and early creative territory exploration • Contribute to global forecast models and scenario planning, in partnership with Commercial Insights and FP&A • Engage with key external stakeholders (KOLs, patient advocacy, payers, partners) to gather deep insights that influence strategic decision‑making • Represent Commercial in business development evaluations of opportunities relevant to empasiprubart’s lifecycle • Help build and scale the commercial development function within the empasiprubart franchise • Role‑model argenx values and reinforce cross‑functional collaboration, contributing to a high‑performance, patient‑focused culture • Support onboarding and capability building of new team members, consistent with organizational goals